Exercise and Sports Participation in Children with Cardiomyopathy: A Review

IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Current Treatment Options in Cardiovascular Medicine Pub Date : 2023-09-15 DOI:10.1007/s11936-023-01006-2

Imran R. Masood, Jonathan B. Edelson

{"title":"Exercise and Sports Participation in Children with Cardiomyopathy: A Review","authors":"Imran R. Masood, Jonathan B. Edelson","doi":"10.1007/s11936-023-01006-2","DOIUrl":null,"url":null,"abstract":"Abstract Purpose of review There are numerous health benefits to exercise, including improved cardiovascular, metabolic, and mental health. Despite these many benefits, children with cardiomyopathy have been traditionally restricted from engaging in exercise or participating in organized sports. The purpose of this review is to summarize the current literature regarding the utility of cardiopulmonary exercise testing, discuss the safety and benefits of exercise and sports participation in children with cardiomyopathy, and to identify research gaps in the field. Recent findings We highlight relevant literature discussing exercise and sports participation in children with hypertrophic cardiomyopathy, dilated cardiomyopathy, anthracycline-induced cardiomyopathy, and those with ventricular assist device support. We discuss recent literature describing methods for risk stratification. Summary The current literature globally favors promoting exercise and sports participation after appropriate risk stratification. Additionally, we offer guidance for how to safely promote exercise in children with cardiomyopathy.","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"10 1","pages":"0"},"PeriodicalIF":0.8000,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Treatment Options in Cardiovascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s11936-023-01006-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract Purpose of review There are numerous health benefits to exercise, including improved cardiovascular, metabolic, and mental health. Despite these many benefits, children with cardiomyopathy have been traditionally restricted from engaging in exercise or participating in organized sports. The purpose of this review is to summarize the current literature regarding the utility of cardiopulmonary exercise testing, discuss the safety and benefits of exercise and sports participation in children with cardiomyopathy, and to identify research gaps in the field. Recent findings We highlight relevant literature discussing exercise and sports participation in children with hypertrophic cardiomyopathy, dilated cardiomyopathy, anthracycline-induced cardiomyopathy, and those with ventricular assist device support. We discuss recent literature describing methods for risk stratification. Summary The current literature globally favors promoting exercise and sports participation after appropriate risk stratification. Additionally, we offer guidance for how to safely promote exercise in children with cardiomyopathy.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

心肌病儿童的运动和运动参与:综述

运动对健康有许多好处，包括改善心血管、代谢和心理健康。尽管有这些好处，患有心肌病的儿童一直被限制从事锻炼或参加有组织的体育运动。本综述的目的是总结目前关于心肺运动试验的文献，讨论运动和运动参与对心肌病儿童的安全性和益处，并确定该领域的研究空白。我们重点介绍了相关文献，讨论了患有肥厚性心肌病、扩张性心肌病、蒽环类药物引起的心肌病和心室辅助装置支持的儿童的运动和运动参与。我们讨论了描述风险分层方法的最新文献。目前的文献普遍倾向于在适当的风险分层后促进锻炼和体育参与。此外，我们还提供了如何安全地促进心肌病儿童运动的指导。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Treatment Options in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine

CiteScore

2.00

自引率

0.00%

发文量

期刊介绍： This journal aims to review the most important, recently published treatment-related advances in cardiovascular medicine. By providing clear, insightful, balanced contributions by international experts, the journal intends to elucidate novel approaches to treatment in those affected by the spectrum of cardiovascular-related diseases and conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as coronary artery disease, cerebrovascular disease and stroke, heart failure, pediatric and congenital heart disease, and valvular, myocardial, pericardial, and cardiopulmonary diseases. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known figures in the field, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.